Skip to content

Clinical trials

Phase 2 Leukemia, Erythroblastic, Acute trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Erythroblastic, Acute Phase: Phase 2 Country / region: United States Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20013
20021
20031
20046
20051
20066
20072
20087
20092
20104
20115
20121
20131
20144
20151
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Terminated13
Unknown status2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)17
Fred Hutchinson Cancer Center8
Case Comprehensive Cancer Center6
SWOG Cancer Research Network4
Alliance for Clinical Trials in Oncology3
Northwestern University3
Roswell Park Cancer Institute3
Memorial Sloan Kettering Cancer Center2
Barbara Ann Karmanos Cancer Institute1
City of Hope Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Erythroblastic, Acute62
Leukemia, Myeloid, Acute60
Leukemia, Megakaryoblastic, Acute58
Leukemia, Monocytic, Acute55
Leukemia, Myelomonocytic, Acute53
Congenital Abnormalities43
Leukemia28
Leukemia, Basophilic, Acute13
Leukemia, Eosinophilic, Acute13
Myelodysplastic Syndromes12

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.